Anxiety: assessment and treatment

Anxiety is a normal response to danger and, at moderate levels, helps us prepare and respond. It becomes a disorder when it is disproportionate, persistent and hard to control, and starts to limit personal and working life. Treatment rests mainly on cognitive behavioural therapy and, when indicated, certain antidepressants.

Etching of a vast imaginary interior with staircases, bridges, arches and ropes crossing on many levels, a drawbridge at the centre and small human figures, with no evident way out

Piranesi’s imaginary prisons, with endless stairways and spaces with no apparent exit, became a cultural image of unease. Anxiety, as it is understood today, is a common and treatable condition.

Giovanni Battista Piranesi, The Drawbridge, plate VII of Carceri d’invenzione, c. 1749–50. Etching, engraving and scratching. The Metropolitan Museum of Art, New York. Public domain. Catalogue record (external site)

In brief

  • Benzodiazepines bring quick relief, but continued use leads to tolerance and dependence.
  • Before treatment, medical causes that mimic anxiety, such as thyroid problems, are looked for.
  • When physical symptoms predominate, liaising with the GP or a cardiologist can be helpful.
  • Regular sleep, less caffeine and alcohol and physical activity enhance the other treatment measures.

Forms and symptoms

Anxiety takes several forms, each with its own symptoms and situations.

    • Excessive worry about many topics
    • Tension, fatigue and poor sleep
    • Sudden attacks of intense fear, peaking within minutes
    • Fear of another attack, and avoidance
  • Social anxiety and specific phobias

    • Fear of being judged negatively
    • Or of specific objects and situations
Read more

Excessive, hard-to-control worry about several topics (health, work, family, money) on most days, for months, with muscle tension, fatigue, irritability, difficulty concentrating and disturbed sleep. More in Generalised anxiety disorder.

Sudden attacks of intense fear that peak within minutes, with palpitations, shortness of breath, chest tightness, trembling, dizziness, tingling and a feeling of losing control or dying. They are often followed by fear of another attack and avoidance of places or situations (agoraphobia).

Marked fear of social or performance situations, in which the person fears being judged negatively (social anxiety), or of specific objects and situations, with disproportionate avoidance.

When to seek an assessment

  • Persists for weeks or months
  • Leads you to avoid important situations
  • Disturbs sleep
  • Repeated emergency visits for physical symptoms
  • Alcohol or sedatives to control it

What the assessment involves

It characterises the symptoms and their impact and looks for what can mimic or worsen anxiety.

  • Depression alongside it
  • Substance use
  • Medical causes: thyroid, arrhythmias, caffeine
Read more

Besides characterising the symptoms and their impact, the assessment looks for associated depression, substance use and medical causes that mimic anxiety, such as thyroid disorders, cardiac arrhythmias, medication effects or excess caffeine. When physical symptoms predominate, liaising with your GP or a cardiologist can be helpful.

Treatment

  • Psychotherapy

    • Cognitive behavioural therapy (CBT): the best evidence
    • Gradual exposure to what is avoided
  • Medication

    • First line: SSRIs or SNRIs
    • Benzodiazepines only briefly
  • In daily life

    • Regular sleep
    • Less caffeine and alcohol
    • Physical activity
Read more
  • Psychotherapy: cognitive behavioural therapy is the psychological treatment with the best evidence, including gradual exposure to avoided situations.
  • Medication: some antidepressants (SSRIs or SNRIs) are first-line pharmacological treatments for long-term management. Other medicines may be considered in specific situations.
  • Benzodiazepines: they bring quick relief, but continued use leads to tolerance and dependence. They are generally reserved for short, well-defined periods.

Research with LSD and psilocybin in anxiety is summarised in Psychedelics for anxiety; the general framework, safety and state of research are on psychedelic-assisted therapy.

Regular sleep, less caffeine and alcohol, and physical activity are part of treatment and enhance the other measures.

Research: psychedelics for anxiety and psychedelic-assisted therapy.

In numbers

Anxiety in Portugal: how severe cases were over one year

  1. Mild5.3%
  2. Moderate8.0%
  3. Severe3.2%
  4. Total (any severity)16.5%
12-month prevalence in adults, by severity. Source: Portuguese National Mental Health Survey (2013), in DGS, Portugal – Saúde Mental em números 2013, table 31.4

Frequently asked questions

Is a panic attack dangerous?

It is a very intense experience, but an isolated panic attack does not damage the heart or cause death. At the first attack, or when in doubt, it is important to rule out a medical cause, especially a cardiac one.

References

  1. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management [Internet]. Clinical guideline CG113. London: NICE; 2011 [updated 2020 Jun 15; cited 2026 Nov 12]. Source (external site)
  2. Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(5):403-39. doi:10.1177/0269881114525674 DOI (external site)
  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed., text rev. (DSM-5-TR). Washington (DC): American Psychiatric Association Publishing; 2022. doi:10.1176/appi.books.9780890425787 DOI (external site)
  4. Direção-Geral da Saúde, Programa Nacional para a Saúde Mental. Portugal – Saúde Mental em números – 2013 [Internet]. Lisboa: DGS; 2013 [cited 2026 Nov 12]. Source (external site)
  5. World Health Organization. Anxiety disorders [Internet]. Geneva: WHO; 2026 Sep 15 [cited 2026 Nov 12]. Source (external site)
  6. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655-79. doi:10.1016/j.euroneuro.2011.07.018 DOI (external site)
  7. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327-35. doi:10.31887/DCNS.2015.17.3/bbandelow DOI (external site)
  8. Xavier M, Baptista H, Mendes JM, Magalhães P, Caldas-de-Almeida JM. Implementing the World Mental Health Survey Initiative in Portugal – rationale, design and fieldwork procedures. Int J Ment Health Syst. 2013;7(1):19. doi:10.1186/1752-4458-7-19 DOI (external site)

This page is for information only and does not replace an individual medical assessment.

Written and reviewed by Pedro Zuzarte, psychiatrist · Last reviewed:

A psychiatric assessment can be the first step.

Book an appointment

How a consultation works

If you are looking for psychedelic therapy, KETAMED is the clinic dedicated to this field.

Discover KETAMED (opens in a new tab)

Follow KETAMED: Instagram (opens in a new tab) · Facebook (opens in a new tab)